Pelvic lymphadenectomy for localized prostate cancer

Area of Science:

• Urology
• Oncology
• Medical Imaging

Background:

• Prostate specific antigen (PSA) era leads to more localized prostate cancer diagnoses.
• Accurate lymph node status is critical for treatment selection, monitoring, and recurrence detection in prostate cancer.
• Lymph node invasion (LNI) is a key prognostic factor for patients undergoing curative treatment.

Purpose of the Study:

• To evaluate the importance of lymph node staging in localized prostate cancer.
• To discuss the limitations of current radiological staging methods (CT, MRI, PET).
• To review the controversies surrounding pelvic lymphadenectomy (PLND) in prostate cancer management.

Main Methods:

• Review of existing literature on lymph node staging in prostate cancer.
• Analysis of the accuracy of radiological imaging and nomograms for lymph node staging.
• Discussion of the surgical approach, including pelvic lymphadenectomy (PLND).

Main Results:

• Radiological methods like CT, MRI, and PET scans have limited reliability in lymph node staging.
• Statistical models (nomograms) for predicting lymph node status show accuracy not exceeding 78%.
• Pelvic lymphadenectomy (PLND) remains a cornerstone for lymph node staging, despite ongoing debates.

Conclusions:

• Accurate preoperative lymph node staging is essential for localized prostate cancer management.
• Current imaging and nomograms are insufficient for definitive lymph node staging.
• Further clarification is needed regarding the necessity, extent, morbidity, and value of pelvic lymphadenectomy (PLND).